Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients
, , , , , y
20 oct 2022
Acerca de este artículo
Publicado en línea: 20 oct 2022
Páginas: 265 - 270
DOI: https://doi.org/10.2478/enr-2022-0028
Palabras clave
© 2022 Suleyman Baldane et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Baldane, Suleyman
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Celik, M
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Kebapcilar, Levent
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Ipekci, Suleyman Hilmi
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Abusoglu, Sedat
Department Biochemistry, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Yilmaz, Huseyin
Department of Surgery, Faculty of Medicine, Selcuk UniversityKonya, Turkey
Alptekin, Husnu
Department of Surgery, Faculty of Medicine, Selcuk UniversityKonya, Turkey